---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-007459"
form_type: "8-K"
ticker: "MYO"
cik: "0001369290"
company_name: "MYOMO, INC."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:17:29.828505+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Myomo Q4 revenue flat at $4.0M; net loss improves to $0.29/share

## Summary
- Q4 product revenue $4.0M, flat YoY and up 2% sequentially; 101 units (down 6% YoY).
- Net loss attributable to common stockholders $2.2M ($0.29/share) vs $3.4M ($0.52) prior year.
- Gross margin 65.0% (down from 77.4% YoY) due to inflationary costs; operating expenses down 17%.
- Patient pipeline added 387 new candidates (+75% YoY); cost per pipeline add down 45% to $2,665.
- Jan 2023 workforce cut 12% to save ~$2.0M; guided Q1 product revenue +15-20% YoY, FY +20-30%.

## SEC filing metadata
- accession: 0000950170-23-007459
- form_type: 8-K
- ticker: MYO
- cik: 0001369290
- company_name: MYOMO, INC.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1369290/000095017023007459/0000950170-23-007459-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1369290/000095017023007459/myo-20230313.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-007459
- JSON: https://secwatch.observer/filing/0000950170-23-007459.json
- Plain text: https://secwatch.observer/filing/0000950170-23-007459.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.